360biolabs, a BioAgilytix company Email Format

Biotechnology ResearchVictoria, Australia51-200 Employees

360biolabs is a biotechnology research organization that provides bioanalytical and specialty laboratory services to support Phase I-III clinical studies. It operates laboratories in Melbourne and Brisbane, with a global team and additional facilities in the United States and Europe. The company adheres to GLP, GCP and ISO 17025, and its quality systems align with ICH, FDA, and EMA guidelines to ensure high-quality results in clinical trials. Its work includes method development, technology transfer, and assay validation conducted within these standards.

It serves pharmaceutical and biotechnology partners requiring support across stages of clinical development, delivering a broad range of analytical and central-lab services for clinical programs. In 2021, 360biolabs became part of BioAgilytix through acquisition and ongoing collaboration, reflecting integration into a global contract research network. Based in Melbourne, Victoria, Australia, the organization operates across Australia and New Zealand and maintains an international presence through its affiliations.

Sign up for free to view info

Company overview Employee directory